These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3907579)

  • 1. Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression.
    Stewart JW; McGrath PJ; Liebowitz MR; Harrison W; Quitkin F; Rabkin JG
    Arch Gen Psychiatry; 1985 Dec; 42(12):1148-53. PubMed ID: 3907579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.
    Stewart JW; Quitkin FM; Liebowitz MR; McGrath PJ; Harrison WM; Klein DF
    Arch Gen Psychiatry; 1983 Feb; 40(2):202-7. PubMed ID: 6337580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.
    Bloch M; Schwartzman Y; Bonne O; Lerer B
    J Clin Psychopharmacol; 1997 Feb; 17(1):44-8. PubMed ID: 9004056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R; Bech P; Mellergård M; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethological assessment of the DSM-III subtyping of unipolar depression.
    Troisi A; Pasini A; Bersani G; Grispini A; Ciani N
    Acta Psychiatr Scand; 1990 Jun; 81(6):560-4. PubMed ID: 2378250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.
    Heiligenstein JH; Tollefson GD; Faries DE
    Int Clin Psychopharmacol; 1993; 8(4):247-51. PubMed ID: 8277143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.
    Roth D; Mattes J; Sheehan KH; Sheehan DV
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):929-39. PubMed ID: 2126144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.
    Remick RA; Keller FD; Buchanan RA; Gibson RE; Fleming JA
    Can J Psychiatry; 1988 Oct; 33(7):590-4. PubMed ID: 3058290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study.
    Wroblewski BA; Joseph AB; Cornblatt RR
    J Clin Psychiatry; 1996 Dec; 57(12):582-7. PubMed ID: 9010122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to desipramine treatment in adolescent major depression.
    Boulos C; Kutcher S; Marton P; Simeon J; Ferguson B; Roberts N
    Psychopharmacol Bull; 1991; 27(1):59-65. PubMed ID: 1862207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of RDC, DSM-III, DSM-III-R diagnostic criteria for generalized anxiety disorder.
    Wolk SI; Horwath E; Goldstein RB; Wickramaratne P; Weissman MM
    Anxiety; 1996; 2(2):71-9. PubMed ID: 9160604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The difference between depression and melancholia: two distinct conditions that were combined into a single category in DSM-III].
    Ohmae S
    Seishin Shinkeigaku Zasshi; 2012; 114(8):886-905. PubMed ID: 23012851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH
    Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparative study of desipramine hydrochloride and diazepam in the control of mixed anxiety/depression symptomatology.
    Kleber RJ
    J Clin Psychiatry; 1979 Apr; 40(4):165-70. PubMed ID: 370109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of adinazolam and desipramine in the treatment of major depression.
    Kennedy SH; de Groot J; Ralevski E; Reed K
    Int Clin Psychopharmacol; 1991; 6(2):65-76. PubMed ID: 1960382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melancholic/endogenous depression and response to somatic treatment and placebo.
    Peselow ED; Sanfilipo MP; Difiglia C; Fieve RR
    Am J Psychiatry; 1992 Oct; 149(10):1324-34. PubMed ID: 1388334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DSM-III personality disorders and the outcome of treated panic disorder.
    Reich JH
    Am J Psychiatry; 1988 Sep; 145(9):1149-52. PubMed ID: 2901236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized anxiety disorder in patients with major depression: is DSM-IV's hierarchy correct?
    Zimmerman M; Chelminski I
    Am J Psychiatry; 2003 Mar; 160(3):504-12. PubMed ID: 12611832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.